If the clinical trials are successful, the pharmaceutical company submits a New Drug Application (NDA) to the FDA. The NDA includes all data from the clinical trials, as well as information on the drug's manufacturing, labeling, and proposed use. The FDA reviews the NDA to determine whether the drug is safe and effective for its intended use.
